Artificial iris

An artificial iris is a surgically implanted device to treat damage or absence of the iris of the eye.[1]

In 2018, the United States Food and Drug Administration approved the first artificial iris, CustomFlex Artificial Iris developed and produced by HumanOptics Holding AG, made of medical grade silicone.[2]

The device improves vision by controlling the amount of light let into the eye. It also improves cosmetic appearance.[2] There are a number of surgical techniques for implanting the prosthetic.[3]

References

"Iris Implants Advance—but Face Continuing Challenges". American Academy of Ophthalmology. 1 February 2013.
Commissioner, Office of the (24 March 2020). "Press Announcements - FDA approves first artificial iris". www.fda.gov.
Mayer, Christian; Tandogan, Tamer; Hoffmann, Andrea E.; Khoramnia, Ramin (June 2017). "Artificial iris implantation in various iris defects and lens conditions". Journal of Cataract & Refractive Surgery. 43 (6): 724–731. doi:10.1016/j.jcrs.2017.06.003. PMID 28732604.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] "Iris Implants Advance—but Face Continuing Challenges". American Academy of Ophthalmology. 1 February 2013.

[fda-2] Commissioner, Office of the (24 March 2020). "Press Announcements - FDA approves first artificial iris". www.fda.gov.

[3] Mayer, Christian; Tandogan, Tamer; Hoffmann, Andrea E.; Khoramnia, Ramin (June 2017). "Artificial iris implantation in various iris defects and lens conditions". Journal of Cataract & Refractive Surgery. 43 (6): 724–731. doi:10.1016/j.jcrs.2017.06.003. PMID 28732604.